Giuseppina Sannino
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma.
Journal: Nature communications
Published: November 24, 2020
Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma.
Journal: Molecular oncology
Published: June 30, 2019
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.
Journal: EBioMedicine
Published: June 12, 2019
Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma.
Journal: International journal of cancer
Published: May 29, 2019
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes.
Journal: Nature communications
Published: February 15, 2019
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma.
Journal: Cell death & disease
Published: December 09, 2018
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 21, 2018
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.
Journal: International journal of cancer
Published: September 17, 2018
Systematic identification of cancer-specific MHC-binding peptides with RAVEN.
Journal: Oncoimmunology
Published: April 25, 2018
Next steps in Ewing sarcoma (epi-)genomics.
Journal: Future oncology (London, England)
Published: June 08, 2017
Last Updated: 09/26/2026